BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 34819743)

  • 1. The correlation between high-risk HPV infection and precancerous lesions and cervical cancer.
    Ma X; Yang M
    Am J Transl Res; 2021; 13(9):10830-10836. PubMed ID: 34650762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.
    Zhao FH; Lin MJ; Chen F; Hu SY; Zhang R; Belinson JL; Sellors JW; Franceschi S; Qiao YL; Castle PE;
    Lancet Oncol; 2010 Dec; 11(12):1160-71. PubMed ID: 21075054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
    do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
    Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
    Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
    J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.
    He H; Pan Q; Pan J; Chen Y; Cao L
    J Clin Lab Anal; 2020 Jul; 34(7):e23257. PubMed ID: 32100923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Four Natural Molecules-EGCG, Folic Acid, Vitamin B12, and HA-To Counteract HPV Cervical Lesions: A Case Report.
    Grandi G; Botticelli L; Fraia PD; Babalini C; Masini M; Unfer V
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing cervical cancer: what are the risks and benefits of different treatments?
    Saul H; Cassidy S; Imison C; Athanasiou A; Kyrgiou M
    BMJ; 2023 Dec; 383():2802. PubMed ID: 38084440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.
    Ye J; Zheng L; He Y; Qi X
    MedComm (2020); 2023 Oct; 4(5):e368. PubMed ID: 37719443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses.
    Grabowski DC; Kansal AR; Goldman DP; Lakdawalla DN
    JAMA Netw Open; 2023 May; 6(5):e2315823. PubMed ID: 37234005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review.
    Li J; Zhang X; Wang P; Li W
    Pharmgenomics Pers Med; 2021; 14():1457-1461. PubMed ID: 34819743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
    Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
    Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.